Guest guest Posted February 5, 2004 Report Share Posted February 5, 2004 The February 5 issue of The New England Journal of Medicine (NEJM) reports on the results of a Cystic Fibrosis Foundation-supported study that confirms that people with cystic fibrosis (CF) have an imbalance of fatty acids. These findings may lead to new specialized therapies for people with CF. You may remember hearing about similar research in 1999, which showed that CF mice had low levels of arachidonic acid (AA) and high levels of docosahexaenoic (DHA) acid. The research published in the NEJM provides further confirmation of this imbalance in humans, and also links it with the defective CFTR protein. This is significant because, before now, CF researchers were not able to link the fatty-acid imbalance to CFTR. It must be cautioned that this research is still in the very early stages and no studies have yet shown that supplementing DHA would be beneficial for people with CF. The CF Foundation will continue to fund DHA research and will move it forward cautiously and expeditiously. For more information, please refer to CF Foundation's Web site at http://www.cff.org/content.cfm?contentID=502. Hamilton Associate Executive Director Cystic Fibrosis Foundation 1025 Ashworth Road #512 West Des Moines, IA 50265 Phone: Website: www.cff.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.